FBIL
LEGN icon

First Beijing Investment Ltd’s Legend Biotech LEGN Stock Holding History

First Beijing Investment Ltd’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,296,335
Closed -$41.5M – 13
2026
Q1 		$41.5M Buy
+2,296,335
New +$43.8M 1.79% 5

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

First Beijing Investment Ltd's LEGN Position: Q2 2026 in Review

First Beijing Investment Ltd sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 2,296,335 shares — an estimated $41.5M sold.

First Beijing Investment Ltd first reported a position in LEGN in Q1 2026 and held it in 1 quarter. The position peaked at $41.5M in Q1 2026. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • First Beijing Investment Ltd reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • First Beijing Investment Ltd sold 2,296,335 Legend Biotech shares in Q2 2026, an estimated $41.5M.
  • First Beijing Investment Ltd first reported a position in Legend Biotech in Q1 2026 and held it in 1 quarter.
  • First Beijing Investment Ltd's Legend Biotech position peaked at $41.5M in Q1 2026.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on First Beijing Investment Ltd's 13F filing for Q2 2026, filed 12 Aug 2026.